Fogdog
Well-Known Member
Oh man, that's so cool.
Pandemic 2020
- Thread starter Jimdamick
- Start date
- Status
captainmorgan
Well-Known Member
DIY-HP-LED
Well-Known Member
To bad trumpers don't read, much less the obits, you'll see it a lot with standard boilerplate paragraphs, I'll volunteer to write a few for them pro bono to tack on the end of obits. KBT might be a popular inscription on tombstones, KBT Killed By Trump, or maybe MBT&R Murdered By Trump & Republicans.
DIY-HP-LED
Well-Known Member
Make a great Lincoln project ad with these obits
people often ask what they can do to change the others' minds- you can't. it must come from within = trumpers needlessly dying and the survivors no longer accepting of a cult leader..louie gohmert doubled down when he had the opportunity..he had a choice and could've been a hero for texas, you can see how deep this runs red v. blue..racism is much, much worse.
DIY-HP-LED
Well-Known Member
I'll bet there are at least 10 million Americans who voted for Trump in 2016, who also feel like they signed their own death warrant. Hillary got 3 million more votes last time, how many will Joe get this time? How many red states will he win in 2020? Forget the swing states, they are in the rear view mirror, Texas and GEORGIA! are the new swing states, Florida is leaning democratic and Trump's covid nightmare ain't over for them yet, or other big red states with tons of electoral votes. Losing Texas would mean a huge loss of electoral college votes, as would Florida, Trump has no path to reelection, covid is only going to get worse in those places. The country needs to lock down nationally before the election to save itself from catastrophe, especially in the southern and rural red states. Hospital systems are being overwhelmed and it is going to get much worse in many of those places before it gets better, ya might see public panic in some, as the threat escalates and people are dying at home with lineups outside local hospitals on local TV. All news is local they say and in these circumstances people are going to be watching local news, Trump's words and actions will be filtered through that local context.
www.cnn.com
Teacher: I may have signed death warrant by voting for Trump
Nancy Shively, an Oklahoma teacher, voted for Trump in 2016. Now, amid a heated debate on reopening schools and watching his response to the pandemic, she says she fears for her life.
Teacher: I may have signed death warrant by voting for Trump - CNN Video
Nancy Shively, an Oklahoma teacher, voted for Trump in 2016. Now, amid a heated debate on reopening schools and watching his response to the pandemic, she says she fears for her life.
www.cnn.com
Teacher: I may have signed death warrant by voting for Trump
Nancy Shively, an Oklahoma teacher, voted for Trump in 2016. Now, amid a heated debate on reopening schools and watching his response to the pandemic, she says she fears for her life.
VILEPLUME
Well-Known Member
i'll bet a lot of people said the other day..'holy shit that fvcker died'- it became real for herman cain.I'll bet there are at least 10 million Americans who voted for Trump in 2016, who also feel like they signed their own death warrant. Hillary got 3 million more votes last time, how many will Joe get this time? How many red states will he win in 2020? Forget the swing states, they are in the rear view mirror, Texas and GEORGIA! are the new swing states, Florida is leaning democratic and Trump's covid nightmare ain't over for them yet, or other big red states with tons of electoral votes. Losing Texas would mean a huge loss of electoral college votes, as would Florida, Trump has no path to reelection, covid is only going to get worse in those places. The country needs to lock down nationally before the election to save itself from catastrophe, especially in the southern and rural red states. Hospital systems are being overwhelmed and it is going to get much worse in many of those places before it gets better, ya might see public panic in some, as the threat escalates and people are dying at home with lineups outside local hospitals on local TV. All news is local they say and in these circumstances people are going to be watching local news, Trump's words and actions will be filtered through that local context.
Teacher: I may have signed death warrant by voting for Trump - CNN Video
Nancy Shively, an Oklahoma teacher, voted for Trump in 2016. Now, amid a heated debate on reopening schools and watching his response to the pandemic, she says she fears for her life.
Teacher: I may have signed death warrant by voting for Trump
Nancy Shively, an Oklahoma teacher, voted for Trump in 2016. Now, amid a heated debate on reopening schools and watching his response to the pandemic, she says she fears for her life.
i noticed it doesn't say death..a smart attorney and you have yourself a class action
DIY-HP-LED
Well-Known Member
Here in NS we are having a case or two of covid pop up, but have it largely under control for a couple of months or more. A few days ago we had mask laws kick in for inside stores and restaurants, public transport etc, few were wearing them before, well over 90% are now from what I've seen 99%, most shoppers in the stores are women and they are generally smarter than men! 
I haven't been out too much to stores and such and they aren't required outdoors and I'm just making quick trips to the park and there are no many masks there.
We had an early response and most cases came in from HFX international airport.
N.S. reports no new COVID-19 cases; 2 more cases resolved
HALIFAX -- Nova Scotia is reporting no new cases of COVID-19 on Monday, and two of the four active cases in the province are now considered resolved.
The QEII Health Sciences Centre's microbiology lab completed 215 COVID-19 tests on Sunday, and continues to operate 24-hours a day.
Nova Scotia has 64,412 negative test results of the virus, 1,071 positive COVID-19 cases, and 64 deaths. One-thousand-and-five cases are now considered resolved.
The cases in the province range from under 10 to over 90-years-old.
Nobody is currently in hospital being treated for the disease.
I haven't been out too much to stores and such and they aren't required outdoors and I'm just making quick trips to the park and there are no many masks there.We had an early response and most cases came in from HFX international airport.
N.S. reports no new COVID-19 cases; 2 more cases resolved
Nova Scotia is reporting no new cases of COVID-19 on Monday, and two of the four active cases in the province are now considered resolved.
atlantic.ctvnews.ca
N.S. reports no new COVID-19 cases; 2 more cases resolved
HALIFAX -- Nova Scotia is reporting no new cases of COVID-19 on Monday, and two of the four active cases in the province are now considered resolved.
The QEII Health Sciences Centre's microbiology lab completed 215 COVID-19 tests on Sunday, and continues to operate 24-hours a day.
Nova Scotia has 64,412 negative test results of the virus, 1,071 positive COVID-19 cases, and 64 deaths. One-thousand-and-five cases are now considered resolved.
The cases in the province range from under 10 to over 90-years-old.
Nobody is currently in hospital being treated for the disease.
DIY-HP-LED
Well-Known Member
Some good news on convalescent plasma
www.wsj.com
Convalescent Plasma Reduced Death Rate Among Covid-19 Patients, Study Data Signals
Hospitalized patients who got earlier transfusions of blood plasma rich in antibodies to the coronavirus show a lower mortality rate
Hospitalized Covid-19 patients who received transfusions of blood plasma rich with antibodies from recovered patients reduced their mortality rate by about 50%, according to researchers running a large national study.
The researchers presented their data analysis Saturday in a webinar for physicians interested in learning about so-called convalescent plasma, with data slides that were reviewed by The Wall Street Journal. The researchers said they saw signs that the treatment might be working in patients who received high levels...
Paywall
WSJ News Exclusive | Convalescent Plasma Reduced Death Rate Among Covid-19 Patients, Study Data Signals
Hospitalized Covid-19 patients who received transfusions of blood plasma rich with antibodies from recovered patients reduced their mortality rate by about 50%, according to researchers running a large national study.
www.wsj.com
Convalescent Plasma Reduced Death Rate Among Covid-19 Patients, Study Data Signals
Hospitalized patients who got earlier transfusions of blood plasma rich in antibodies to the coronavirus show a lower mortality rate
Hospitalized Covid-19 patients who received transfusions of blood plasma rich with antibodies from recovered patients reduced their mortality rate by about 50%, according to researchers running a large national study.
The researchers presented their data analysis Saturday in a webinar for physicians interested in learning about so-called convalescent plasma, with data slides that were reviewed by The Wall Street Journal. The researchers said they saw signs that the treatment might be working in patients who received high levels...
Paywall
DIY-HP-LED
Well-Known Member
More on convalescent plasma treatment, this is an early look from a preprint article that is causing a buzz among the experts, locking down will do more in America right now. I would expect a major drive on for donations now and perhaps even Trump might push it, since the red states are getting hammered. Donald fucks up everything he touches thought and if it competed with a favorite pharmaceutical corporation he might also try to suppress it.
--------------------------------------------------------------------------------------------------------------------------------------------------------
www.livescience.com
Convalescent plasma could reduce death from COVID-19, early data suggests
COVID-19 patients treated with the blood of those who have recovered from the infection die at significantly lower rates than those given standard treatments alone, according to a preliminary analysis.
In their analysis, posted July 30 to the preprint database bioRxiv, the researchers looked at a dozen trials where hospitalized COVID-19 patients received convalescent plasma (CP) therapy — a treatment that involves drawing blood plasma from recovered patients and injecting the antibody-rich fluid into sick patients. The 12 trials, conducted at various sites around the world, included more than 800 participants in total, and when taken together, suggest that patients given plasma were less than half as likely to die as patients given other treatments, according to the report.
Specifically, the mortality rate among patients given plasma was 13%, compared with 25% among patients given standard treatments. While that's trending in the right direction, the new analysis wasn't peer reviewed, and neither was some of the trial data the analysis looked at. What's more, only three of the 12 studies were randomized controlled trials (RCTs), where patients are randomly assigned to receive a treatment or standard of care, which is the gold standard for assessing medical treatments.
"All studies come with limits, and basically what we're trying to do is provide a very high-level overview" of the data currently available, said author Dr. Michael Joyner, an anesthesiologist and physician-researcher at the Mayo Clinic in Rochester, Minnesota.
"The report provides a signal of hope that CP is beneficial, although unfortunately, it does not provide the confidence that is required to be able to responsibly recommend CP for the treatment of COVID-19," Dr. Mila Ortigoza, an instructor in the Departments of Medicine and Microbiology at NYU Langone Health, who was not involved in the research, told Live Science in an email. Ortigoza, who is currently co-leading a clinical trial of CP therapy for COVID-19, noted that none of the randomized controlled trials included in the analysis "recruited a sufficient number of participants to be able to make conclusions about efficacy" on their own.
"What the current study really highlights is the need to continue supporting ongoing RCTs of CP" to ensure that they enroll enough patients to provide "indisputable evidence" that the therapy really works, she said.
A positive signal
As scientists design new medications for COVID-19, and clinicians repurpose existing drugs like remdesivir, doctors have also turned to CP therapy to treat the viral infection.
"If you look at convalescent plasma, specifically … [it's] been applied to pandemics at least since the 1918 flu," Joyner said. CP therapies were subsequently used during the 2003 SARS outbreak, caused by a coronavirus related to the one that causes COVID-19, and the 2009 H1N1 pandemic, Ortigoza added.
Because people who have recovered from a disease have mounted an effective immune response, CP therapy offers a way to treat infected patients by borrowing tools from the immune system itself — namely, antibodies that direct the immune system to attack a specific pathogen, or neutralize the bug directly, Live Science previously reported.
Although promising on paper, CP has been difficult to study in practice. Trials of CP conducted during past pandemics often lacked control groups for comparison, meaning the effects of CP could not be weighed against those of an alternate therapy, or the standard of care, Ortigoza said. But in the context of a pandemic, well-controlled trials can be difficult to execute at the scale and speed required to draw clear-cut conclusions for people who may need treatment right away.
more...
--------------------------------------------------------------------------------------------------------------------------------------------------------
Convalescent plasma could reduce death from COVID-19, early data suggests
A new analysis hints that COVID-19 patients treated with the blood of those who have recovered from the infection die at significantly lower rates than those given standard treatments alone.
www.livescience.com
Convalescent plasma could reduce death from COVID-19, early data suggests
COVID-19 patients treated with the blood of those who have recovered from the infection die at significantly lower rates than those given standard treatments alone, according to a preliminary analysis.
In their analysis, posted July 30 to the preprint database bioRxiv, the researchers looked at a dozen trials where hospitalized COVID-19 patients received convalescent plasma (CP) therapy — a treatment that involves drawing blood plasma from recovered patients and injecting the antibody-rich fluid into sick patients. The 12 trials, conducted at various sites around the world, included more than 800 participants in total, and when taken together, suggest that patients given plasma were less than half as likely to die as patients given other treatments, according to the report.
Specifically, the mortality rate among patients given plasma was 13%, compared with 25% among patients given standard treatments. While that's trending in the right direction, the new analysis wasn't peer reviewed, and neither was some of the trial data the analysis looked at. What's more, only three of the 12 studies were randomized controlled trials (RCTs), where patients are randomly assigned to receive a treatment or standard of care, which is the gold standard for assessing medical treatments.
"All studies come with limits, and basically what we're trying to do is provide a very high-level overview" of the data currently available, said author Dr. Michael Joyner, an anesthesiologist and physician-researcher at the Mayo Clinic in Rochester, Minnesota.
"The report provides a signal of hope that CP is beneficial, although unfortunately, it does not provide the confidence that is required to be able to responsibly recommend CP for the treatment of COVID-19," Dr. Mila Ortigoza, an instructor in the Departments of Medicine and Microbiology at NYU Langone Health, who was not involved in the research, told Live Science in an email. Ortigoza, who is currently co-leading a clinical trial of CP therapy for COVID-19, noted that none of the randomized controlled trials included in the analysis "recruited a sufficient number of participants to be able to make conclusions about efficacy" on their own.
"What the current study really highlights is the need to continue supporting ongoing RCTs of CP" to ensure that they enroll enough patients to provide "indisputable evidence" that the therapy really works, she said.
A positive signal
As scientists design new medications for COVID-19, and clinicians repurpose existing drugs like remdesivir, doctors have also turned to CP therapy to treat the viral infection.
"If you look at convalescent plasma, specifically … [it's] been applied to pandemics at least since the 1918 flu," Joyner said. CP therapies were subsequently used during the 2003 SARS outbreak, caused by a coronavirus related to the one that causes COVID-19, and the 2009 H1N1 pandemic, Ortigoza added.
Because people who have recovered from a disease have mounted an effective immune response, CP therapy offers a way to treat infected patients by borrowing tools from the immune system itself — namely, antibodies that direct the immune system to attack a specific pathogen, or neutralize the bug directly, Live Science previously reported.
Although promising on paper, CP has been difficult to study in practice. Trials of CP conducted during past pandemics often lacked control groups for comparison, meaning the effects of CP could not be weighed against those of an alternate therapy, or the standard of care, Ortigoza said. But in the context of a pandemic, well-controlled trials can be difficult to execute at the scale and speed required to draw clear-cut conclusions for people who may need treatment right away.
more...
DIY-HP-LED
Well-Known Member
UncleBuck
Well-Known Member
no it won't.
Fogdog
Well-Known Member
"getting lucky" isn't a great strategy.
"President Biden" has a good clean sound to it. Free from scandals and corruption.
hanimmal
Well-Known Member
So you really are pretending that if the Pandemic is over by November Trump won't run on it?
- Status